Slide 1Responsible Adverse Event (AE) Reporting: Finding Appropriate AE Terms Using CTC v2.0 and CTCAE v3.0 Slide 2 Presentation Outline Responsible Adverse Event (AE) Reporting:…

1.Game Plan for TherapeuticCancer Vaccines style Click to edit Master title Presented by:Mark Shapiro, MBA, MA, RACClick to edit Master title styleNikolas Burlew, RQAP-GLP…

1. EM-No. V. 01 / 2014 2. Whatever your need on Oncology Clinical Trials, ESTERN Medical CRO Group can deliver them with excellence.2 3. At ESTERN Medical, we understand…

Copyright © 2010 Quintiles. 16.15.09-072010 Contact Us: On the web: www.quintiles.com Email: [email protected] From Biomarkers to Diagnostics â The Road to Success…

Slide 1MASCC EGFR Inhibitor Skin Toxicity Tool (MESTT) Multinational Association of Supportive Care in Cancer TM Skin Toxicity Scale (last updated July, 2009) Organizing…

Slide 1 © 2011 ENACCT Inc. All rights reserved. 1© 2014 ENACCT Inc. All rights reserved. 1 Preparing Patients for the Oncology Referral: The Role of the Primary Care Provider…

Older adults and the effects of co-morbidities on cancer treatment Older adults and the effects of co-morbidities on cancer treatment Cheryl Lillegraven MSN, ARNP, ACNS-BC…

Responsible Adverse Event (AE) Reporting: Finding Appropriate AE Terms Using CTC v2.0 and CTCAE v3.0 Presentation Outline AE Reporting Background/History AE Terminology Physician/Investigator…

Responsible Adverse Event (AE) Reporting: Finding Appropriate AE Terms Using CTC v2.0 and CTCAE v3.0 Presentation Outline AE Reporting Background/History AE Terminology Physician/Investigator…

The Slow Move To Quadrivalent Influenza Vaccines Shifting Focus In Ophthalmic Clinical Research Use of Traditional Complementary and Alternative Medicine In the Management…